BVS vs ROP · rev $573.3M vs P/E 41, rev $1.88B
Bioventus Inc (BVS) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
BVS currently screens at market cap $495.1M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the BVS and ROP stock pages for the full models.
Not investment advice.